Protocol for Enhanced Severe Acute Respiratory Illness and Influenza-Like Illness Surveillance for COVID-19 in Africa

  • Version
  • Download 44652
  • File Size 2.68 MB
  • File Count 4
  • Create Date 9 April 2020
  • Last Updated 21 August 2020

Protocol for Enhanced Severe Acute Respiratory Illness and Influenza-Like Illness Surveillance for COVID-19 in Africa

The majority of Member States have sentinel surveillance systems for influenza-like illness (ILI) and SARI and they take part in the Global Influenza Surveillance and Response System (GISRS). They can leverage these systems for COVID-19 because they investigate patients with similar clinical presentation to COVID-19.

To support the process of moving towards increased testing of SARI cases, and to better understand the presence of undetected cases among SARI/ILI patients, Africa CDC is supporting Member States to integrate testing for SARS-CoV2 virus into existing national SARI/ILI sentinel surveillance system.

Attached Files

FileAction
Protocol for Enhanced SARI and ILI Surveillance for COVID-19 in Africa (Portuguese).pdfDownload
Protocol for Enhanced SARI and ILI Surveillance for COVID-19 in Africa (French).pdfDownload
Protocol for Enhanced SARI and ILI Surveillance for COVID-19 in Africa (English).pdfDownload
Protocol for Enhanced SARI and ILI Surveillance for COVID-19 in Africa (Arabic).pdfDownload

This slide deck, presented at the Developing Countries Vaccine Manufacturers Network International Annual General Meeting in October 2024, describes updated results from a study to assess the current and planned state of vaccine manufacturing in Africa and provides insights into what’s needed to develop a robust and sustainable vaccine manufacturing ecosystem.

We surveyed African vaccine manufacturers to better understand their current manufacturing capacity and capabilities, the progress they’ve made since 2023, and their future outlooks. This information can help stakeholders and funders better coordinate and prioritize actions to build a successful African vaccine manufacturing ecosystem.

Corporate author(s): Africa Centres for Disease Control and Prevention (Africa CDC); Clinton Health Access Initiative (CHAI); PATH

Publication date: October 2024

Download Files
FileAction
African Vaccine Manufacturing Mapping | Supply and Demand LandscapeDownload